SCHEMBL6875755

SCHEMBL6875755

C[C@H](NC(=O)Nc1ccc2ccccc2c1)C(N)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.58
▸ NPC1 O15118 4/20 0.58
▸ MAPT P10636 3/20 0.58
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ GAA P10253 1/20 0.55
▸ CA2 P00918 2/20 0.52
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ CYP1A2 P05177 3/20 0.50
▸ CYP2C19 P33261 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ EPHX1 P07099 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ RECQL P46063 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29687055 1.00 RAB9A (0.58) RAB9ANPC1MAPTSMN1; SMN2GAA
SCHEMBL19020205 0.84 RAB9A (0.65) RAB9ANPC1MAPTSMN1; SMN2GAA
SCHEMBL4299166 0.81 RAB9A (0.47) RAB9ANPC1MAPTSMN1; SMN2GAA
SCHEMBL6873113 0.81 HSD17B10 (0.62) RAB9ANPC1MAPTSMN1; SMN2KMT2A
SCHEMBL1903330 0.81 HSD17B10 (0.62) RAB9ANPC1MAPTSMN1; SMN2KMT2A
SCHEMBL29687100 0.79 TSHR (0.76) RAB9ANPC1MAPTSMN1; SMN2GAA
SCHEMBL9547503 0.79 RAB9A (0.89) RAB9ANPC1MAPTSMN1; SMN2GAA
SCHEMBL29687046 0.78 KIF11 (0.58) RAB9ANPC1SMN1; SMN2CA2MEN1
SCHEMBL29686974 0.77 HTR2C (0.45) RAB9ANPC1MAPTSMN1; SMN2MEN1
SCHEMBL29687222 0.76 KIF11 (0.51) RAB9ANPC1MAPTCA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1452522-A2 Novel compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2004-09-01 — — EP disclosed
Send feedback